Table 1.
Comparison of general characteristics between the groups.
| AF medication group (n = 50) | RFA group (n = 50) | χ2/t | P | |
|---|---|---|---|---|
| Sex (n, %) | 0.040 | 0.841 | ||
| Male | 27 (54.00) | 28 (56.00) | ||
| Female | 23 (46.00) | 22 (44.00) | ||
| Age (years) | 62.24 ± 14.36 | 61.89 ± 14.53 | 0.121 | 0.904 |
| Hypertension (n, %) | 0.250 | 0.617 | ||
| Yes | 41 (82.00) | 39 (78.00) | ||
| No | 9 (18.00) | 11 (22.00) | ||
| Diabetes (n, %) | 0.396 | 0.529 | ||
| Yes | 19 (38.00) | 16 (32.00) | ||
| No | 31 (62.00) | 34 (68.00) | ||
| Hyperlipidemia (n, %) | 0.160 | 0.689 | ||
| Yes | 25 (50.00) | 27 (54.00) | ||
| No | 25 (50.00) | 23 (46.00) | ||
| Types of AF (n, %) | 0.053 | 0.817 | ||
| Paroxysmal AF (n, %) | 37 (74.00) | 38 (76.00) | ||
| Persistent AF (n, %) | 13 (26.00) | 12 (24.00) | ||
| Course of disease (months) | 10.53 ± 3.25 | 10.84 ± 3.18 | 0.482 | 0.631 |
| Homocysteine (µmol/L) | 14.64 ± 4.63 | 14.68 ± 4.59 | 0.043 | 0.966 |
Values are mean ± standard deviation or n (%). AF, atrial fibrillation; RFA, radiofrequency ablation.